Projects per year
Personal profile
Education
- 1997-2003 Ph.D., Department and Graduate Institute of Pharmacology, National Taiwan University
- 1993-1997 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2020.08- Director, Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University
- 2015.08- Professor, Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University
- 2015.08- Professor, Graduate Institute of Medical Sciences, Taipei Medical University
- 2011.08-2015.07 Associate Professor, Department of Pharmacology, School of Medicine, Taipei Medical University
- 2007.08- Assistant Professor, Graduate Institute of Medical Sciences, Taipei Medical University
- 2007.08-2011.07 Assistant Professor, Department of Pharmacology, School of Medicine, Taipei Medical University
- 2006.08-2007.07 Assistant Professor, School of Medicine, Taipei Medical University
- 2003.11-2006.07 Postdoctoral Researcher, School of Medicine, Taipei Medical University
Research Interests
- Molecular Pharmacology, Angiogenesis, Signal transduction
Fingerprint
Dive into the research topics where Ming-Jen Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
To Evaluate the Pharmacological Mechanisms of Novel Natural Plant Extracts of Coumarins in Suppressing Angiogenesis, Lymphangiogenesis and Inflammation (2/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Evaluate the Pharmacological Mechanisms of Novel Natural Plant Extracts of Coumarins in Suppressing Angiogenesis, Lymphangiogenesis and Inflammation
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討新穎小分子藥物WMJ-B-07誘導腦瘤細胞免疫檢查點programmed cell death protein-ligand 1下降及細胞死亡之機制
7/1/20 → 2/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
新穎性長鏈烴基醯胺WMJ化合物之抗發炎作用評估與藥理機轉探討
3/1/20 → 2/1/21
Project: C - Project of Alliance › o - Chi Mei Medical Center
-
Anti-Cancer and Anti-Inflammatory Properties of Novel Aliphatic Hydroxamate Derivatives: Hdacs- and Mirna-Mediated Post-Transcriptional and Post-Translational Mechanisms
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB
Hsu, M. J., Chen, H. K., Chen, C. Y., Lien, J. C., Gao, J. Y., Huang, Y. H., Hsu, J. B. K., Lee, G. A. & Huang, S. W., Jun 20 2022, In: Frontiers in Oncology. 12, 862326.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Suppressing VEGF-A/VEGFR-2 Signaling Contributes to the Anti-Angiogenic Effects of PPE8, a Novel Naphthoquinone-Based Compound
Hsu, M. J., Chen, H. K., Lien, J. C., Huang, Y. H. & Huang, S. W., Jul 1 2022, In: Cells. 11, 13, 2114.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascade
Huang, S. W., Chyuan, I. T., Shiue, C., Yu, M. C., Hsu, Y. F. & Hsu, M. J., Jan 1 2020, In: Journal of Cellular and Molecular Medicine. 24, 2, p. 1822-1836 15 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Citations (Scopus) -
A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling
Lien, J. C., Chung, C. L., Huang, T. F., Chang, T. C., Chen, K. C., Gao, G. Y., Hsu, M. J. & Huang, S. W., Oct 1 2019, In: British Journal of Pharmacology. 176, 20, p. 4034-4049 16 p.Research output: Contribution to journal › Article › peer-review
12 Citations (Scopus) -
WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade
Huang, S. W., Yang, H. Y., Huang, W. J., Chen, W. C., Yu, M. C., Wang, S. W., Hsu, Y. F. & Hsu, M. J., Nov 6 2019, In: Frontiers in Oncology. 9, 1188.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)